Chuanbin Wu

16.5k total citations · 6 hit papers
378 papers, 13.2k citations indexed

About

Chuanbin Wu is a scholar working on Pharmaceutical Science, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chuanbin Wu has authored 378 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 162 papers in Pharmaceutical Science, 107 papers in Molecular Biology and 66 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chuanbin Wu's work include Advancements in Transdermal Drug Delivery (90 papers), Advanced Drug Delivery Systems (75 papers) and Drug Solubulity and Delivery Systems (59 papers). Chuanbin Wu is often cited by papers focused on Advancements in Transdermal Drug Delivery (90 papers), Advanced Drug Delivery Systems (75 papers) and Drug Solubulity and Delivery Systems (59 papers). Chuanbin Wu collaborates with scholars based in China, United States and United Kingdom. Chuanbin Wu's co-authors include Xin Pan, Guilan Quan, Yixian Zhou, Boyi Niu, Ying Huang, Ting Wen, Chao Lü, Zhengwei Huang, Yuehong Xu and Kaixin Liao and has published in prestigious journals such as Cell, The Lancet and Physical Review Letters.

In The Last Decade

Chuanbin Wu

365 papers receiving 13.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy

2021 854 citations Yixian Zhou, Guilan Quan et al. Biomaterials profile →
Mesoporous silica nanoparticles for drug and gene delivery

2018 542 citations Yixian Zhou, Guilan Quan et al. profile →
Inhalable Biomineralized Liposomes for Cyclic Ca²⁺-Burst-Centered Endoplasmic Reticulum Stress Enhanced Lung Cancer Ferroptosis Therapy

2023 92 citations Fangqin Fu, Wenhao Wang et al. profile →
Recent Applications of PLGA in Drug Delivery Systems

2024 70 citations Chuanbin Wu et al. profile →
Photodynamic therapy for cancer: mechanisms, photosensitizers, nanocarriers, and clinical studies

2024 61 citations Chuanbin Wu, Zhengwei Huang et al. profile →
Gas-propelled anti-hair follicle aging microneedle patch for the treatment of androgenetic alopecia

2025 14 citations Chao Lü, Guilan Quan et al. Journal of Controlled Release profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Chuanbin Wu	4.7k	3.5k	2.5k	2.2k	1.8k	378	13.2k
Farhan Jalees Ahmad	4.5k 1.0×	3.4k 1.0×	2.1k 0.8×	2.5k 1.1×	1.2k 0.7×	516	14.9k
Claus‐Michael Lehr	8.9k 1.9×	6.1k 1.7×	3.5k 1.4×	4.3k 2.0×	1.8k 1.0×	417	22.0k
Biana Godin	2.4k 0.5×	2.5k 0.7×	2.9k 1.2×	2.3k 1.1×	1.6k 0.9×	104	8.7k
Hatem Fessi	5.7k 1.2×	3.4k 1.0×	3.4k 1.4×	5.6k 2.6×	2.1k 1.2×	216	15.8k
Massimo Fresta	3.1k 0.7×	3.5k 1.0×	1.8k 0.7×	3.1k 1.4×	765 0.4×	219	9.9k
Hans E. Junginger	10.9k 2.3×	4.7k 1.3×	1.1k 0.4×	3.1k 1.4×	879 0.5×	233	17.6k
Alf Lamprecht	3.4k 0.7×	2.2k 0.6×	1.2k 0.5×	2.4k 1.1×	740 0.4×	225	8.9k
Prashant Kesharwani	3.3k 0.7×	8.0k 2.3×	5.5k 2.2×	6.6k 3.1×	2.4k 1.4×	568	20.2k
Arto Urtti	4.9k 1.0×	7.6k 2.2×	2.3k 0.9×	2.6k 1.2×	829 0.5×	418	17.9k
Roberta Cavalli	4.7k 1.0×	3.7k 1.0×	2.4k 1.0×	3.7k 1.7×	1.1k 0.6×	271	11.4k

Countries citing papers authored by Chuanbin Wu

Since Specialization

Citations

This map shows the geographic impact of Chuanbin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanbin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanbin Wu more than expected).

Fields of papers citing papers by Chuanbin Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuanbin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanbin Wu. The network helps show where Chuanbin Wu may publish in the future.

Co-authorship network of co-authors of Chuanbin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chuanbin Wu. A scholar is included among the top collaborators of Chuanbin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuanbin Wu. Chuanbin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peng, Siyuan, et al.. (2024). Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives. Pharmaceutics. 16(2). 161–161. 29 indexed citations

Li, Xiaodie, Minglong Chen, Yànpíng Fù, et al.. (2024). Biomineralized in situ catalytic nanoreactor integrated microneedle patch for on demand immunomodulator supply to combat psoriasis. Theranostics. 14(17). 6571–6586. 5 indexed citations

Wang, Guanlin, Jieyun Li, Wenhao Wang, et al.. (2024). A tailored phytosomes based nose-to-brain drug delivery strategy: Silver bullet for Alzheimer's disease. Bioactive Materials. 44. 97–115. 8 indexed citations

Chen, Qingxin, Jingyang Liu, Ying Huang, et al.. (2024). Fibroin nanodisruptor with Ferroptosis-Autophagy synergism is potent for lung cancer treatment. International Journal of Pharmaceutics. 664. 124582–124582. 7 indexed citations

Wang, Guanlin, Jiayuan Huang, Zhengwei Huang, et al.. (2024). Rivastigmine nasal spray for the treatment of Alzheimer’s Disease: Olfactory deposition and brain delivery. International Journal of Pharmaceutics. 652. 123809–123809. 13 indexed citations

Han, Min Ho, Shiying Zhou, Chuanbin Wu, et al.. (2024). Bimetallic peroxide-based nanotherapeutics for immunometabolic intervention and induction of immunogenic cell death to augment cancer immunotherapy. Biomaterials. 315. 122934–122934. 8 indexed citations

Ren, C., Yue Gao, Siyuan Peng, et al.. (2024). Nanocrystals: Versatile Platform for Traditional Chinese Medicine Delivery. Current Drug Delivery. 23(1). 28–43.

Ding, Li, Guanlin Wang, Jieliang Wang, et al.. (2024). Targeted treatment for biofilm-based infections using PEGylated tobramycin. Journal of Controlled Release. 372. 43–58. 5 indexed citations

Peng, Tingting, et al.. (2024). Microneedle technology for enhanced topical treatment of skin infections. Bioactive Materials. 45. 274–300. 7 indexed citations

10.

Wu, Chuanbin, et al.. (2024). Mechanisms and therapeutic targets of ferroptosis: Implications for nanomedicine design. Journal of Pharmaceutical Analysis. 14(7). 100960–100960. 8 indexed citations

11.

Chen, Minglong, Yue Zhou, Yànpíng Fù, et al.. (2024). Biomaterials-assisted cancer vaccine delivery: preclinical landscape, challenges, and opportunities. Expert Opinion on Drug Delivery. 21(7). 1143–1154. 3 indexed citations

12.

Wang, Liqing, Rui Luo, Zejun Xu, et al.. (2024). Imidazole‐Rich, Four‐Armed Host‐Defense Peptidomimetics as Promising Narrow‐Spectrum Antibacterial Agents and Adjuvants against Pseudomonas Aeruginosa Infections. Advanced Healthcare Materials. 13(27). e2400664–e2400664. 3 indexed citations

13.

Peng, Tingting, et al.. (2023). Engineering Ferroptosis Inhibitors as Inhalable Nanomedicines for the Highly Efficient Treatment of Idiopathic Pulmonary Fibrosis. Bioengineering. 10(6). 727–727. 12 indexed citations

14.

Zhou, Yixian, Biyuan Wu, Chao Lü, et al.. (2023). An oxygen-generating metal organic framework nanoplatform as a “synergy motor” for extricating dilemma over photodynamic therapy. Materials Advances. 4(22). 5420–5430. 6 indexed citations

15.

Deng, Jingwen, Dongyi Xian, Fengyan Han, et al.. (2023). Surface‐Engineered Vanadium Carbide MXenzyme for Anti‐Inflammation and Photoenhanced Antitumor Therapy of Colon Diseases. Advanced Functional Materials. 33(31). 42 indexed citations

16.

Wang, Wenhua, Wenhao Wang, Shiwei Jin, et al.. (2023). Open pocket and tighten holes: Inhalable lung cancer-targeted nanocomposite for enhanced ferroptosis-apoptosis synergetic therapy. Chemical Engineering Journal. 458. 141487–141487. 16 indexed citations

17.

Ren, Tao, Xuewen Wang, Chao Lü, et al.. (2023). Combating multidrug resistance of breast cancer with ginsenoside Rh2-irrigated nano-in-thermogel. International Journal of Pharmaceutics. 650. 123718–123718. 17 indexed citations

18.

He, Jingyu, Lin Gan, Zhiyuan Feng, et al.. (2023). Guard against internal and external: An antibacterial, anti-inflammation and healing-promoting spray gel based on lyotropic liquid crystals for the treatment of diabetic wound. International Journal of Pharmaceutics. 646. 123442–123442. 6 indexed citations

19.

Chen, Yuanzheng, Xun Gu, Yingying Li, et al.. (2023). Co-delivery of drugs by adhesive transdermal patches equipped with dissolving microneedles for the treatment of rheumatoid arthritis. Journal of Controlled Release. 365. 274–285. 23 indexed citations

20.

Wu, Biyuan, Minmin Zhang, Peipei Yang, et al.. (2018). A novel scalable fabrication process for the production of dissolving microneedle arrays. Drug Delivery and Translational Research. 9(1). 240–248. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact